Navigation Links


IGF at Biology News

Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems

Deficiencies of growth hormone and similar compounds may reduce cancer and kidney disease late in life, but also may lead to cartilage degeneration and impaired memory and learning ability, according to research at Wake Forest University Baptist Medical Center and four other institutions. The researchers used a rat model to explore the effects of growth hormone and another compound, IGF-1...
IGF at Biology Products
IGF at Biology Technology
IGF at Medicine News

IGF-1 drug approved by FDA

Insulin like-Growth Factor (IGF-1) is required for both cartilage and bone growth in children’s and the secretion of IGF is mediated by the pituitary gland.// Deficiency of IGF-1 results in impaired growth and is associated with metabolic abnormalities including insulin resistance, increased adiposity and delayed wound healing. IGF-1 drugs helps in production of IGF-1 in children’s with d...

Search For Bigfoot Creature To Be Delayed

An expedition from Singapore in search of 'Bigfoot', an ape-like beast in the Johor forests of Malaysia has been postponed until 21 January 2006. //This has been done on the request of the authorities from Malaysia. This has been revealed by the Singapore Paranormal Investigators (SPI). The media in Malaysia had reported mysterious bite marks and footprints, which had prompted Singapore t...
IGF at Medicine Products

IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor

Description:Insulin-like growth factor 1 (IGF-1) is a polypeptide of 70 amino acids (7650 daltons), and is one of a number of related insulin-like growth factors present in the circulation. The molecule shows approximately 50% sequence homology with proinsulin and has a number of biological activities similar to insulin. The peptide is growth hormone (GH) dependent to a high degree, but there is growing evid...
Company:ALPCO Diagnostics

IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein

Description:IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein...
Company:ALPCO Diagnostics

Insulin-like Growth Factor-I (IGF-I) ELISA

Description:The IDS OCTEIATM IGF-I kit is a two-site ELISA for the quantitative determination of Insulin-like Growth Factor-I (IGF-I) in serum or plasma. The assay uses a highly specific polyclonal "capture" antibody in microtiter wells and a high affinity monoclonal antibody labelled with horseradish peroxidase. A simple sample pre-treatment replaces acid/ethanol extraction to provide for the direct immunoa...
Company:IDS Ltd

IMMULITE/IMMULITE 1000 IGF-I

Description:IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULITE systems can be found in a wide variety of immunoassay testing environments around the world....
Company:Siemens Medical Solutions Diagnostics

IMMULITE 2500 IGF-I

Description:IMMULITE 2500 is a high-throughput immunoassay system built around the many positive attributes of the IMMULITE 2000 with the important addition of Logic Driven Incubation (LDI). LDI technology allows assays to be designed for optimal performance with the fastest possible incubation times. This allows for critical assays such as the cardiac biomarkers and HCG to be run in around 15 mi...
Company:Siemens Medical Solutions Diagnostics

More>>

IGF at Medicine Technology

Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants

RICHMOND, Va.--(BUSINESS WIRE)--Jun 26, 2007 - Insmed Incorporated(Nasdaq:INSM), a biopharmaceutical company focused on thedevelopment and approval of drugs for the treatment of metabolicdiseases with unmet medical needs, today noted the publication ofpromising results of research from three universities regarding thepotential role of insulin-like growth factor binding protein-3(IGFBP-3) in...

Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO

NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - First-in-human results forIMC-A12, a monoclonal antibody developed by ImClone SystemsIncorporated (NASDAQ: IMCL) and targeted to IGF-1R (insulin-likegrowth factor type 1 receptor), were presented at the annualmeeting of the American Society of Clinical Oncology in Chicago.The IGF-IR is expressed on the cell surface of must human cancersand transmits...
Other TagsCalan
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
(Date:7/24/2008)...d talk, they might tell potential suitors, "I like... come slither look. But worms send their valentine...cal code researchers are now cracking, according t...rnal Nature . , Scientists from the University...stitute of Technology and the U.S. Department of A...
(Date:7/24/2008)...on in Taiwan buries as much carbon in the ocean --... in that country all year long combined. , That...ublished in a recent issue of the journal Geology...chemistry of stream water and sediments that were ...ing at full force -- will help scientists develop ...
(Date:7/23/2008)...willing to collectively spend about $1 billion ann... billion metric tons of carbon dioxide per year fo...t would take about that much money to put an end t...ld, one of the top contributors to greenhouse gas ...his type of program could have potential to reduce...
(Date:7/23/2008)...tute of Standards and Technology (NIST) have devel...s of proteins in protein-based pharmaceuticals. Th...s under which scientists can be assured that their...n of protein aggregates, a major concern because o...ogic drug manufacturing. , Proteins, a main cons...
Breaking Biology News(10 mins):Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4NIST trumps the clumps: Making biologic drugs safer 2Telik Announces Preclinical Data Demonstrating Anti Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 670 1Telik Announces Preclinical Data Demonstrating Anti Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 670 2JCI table of contents 3A Oct 25 2007 4646 1JCI table of contents 3A Oct 25 2007 4646 2JCI table of contents 3A Oct 25 2007 4646 3JCI table of contents 3A Oct 25 2007 4646 4JCI table of contents 3A Oct 25 2007 4646 5JCI table of contents 3A Oct 25 2007 4646 6JCI table of contents 3A Oct 25 2007 4646 7JCI table of contents 3A Oct 25 2007 4646 8JCI table of contents 3A Oct 25 2007 4646 9U M to lead disaster aftermath research center 4642 1U M to lead disaster aftermath research center 4642 2Biotech adds Central American markets to Sucanon distribution 4638 1
Other Contentsrenalrenalrenalrenalrenalrenalrenalrenalrenalrepetitiverepetitiverepetitiverepetitiverepetitiverepetitiverepetitiverepliconrepliconbubblebubblebubblebubbleforkforkforkreporterreporterreporterreporterreporterreporterreporterrepressionrepressionrepressionrepressionresidueresidueresidueresidueresidueresidueresidueresidue